As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
How you can devise a cancer prevention action plan.
How to love yourself — and your selfies — without filters or fillers.
Data Collection Study on Patients Receiving a DRG Stimulator
Clinical Trial Title:
A post-approval study to evaluate targeted SCS (DRG) stimulation for the management of moderate to severe chronic, intractable, pain of the lower limbs due to CRPS types I and II.
Clinical Trial Protocol ID:
16052703
Clinical Trial Investigator Name:
Timothy R. Lubenow, MD
Clinical Trial Protocol Description:
Research study to collect data on patients who are receiving a DRG stimulator.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Have a DRG stimulator implant scheduled.
You will be excluded from the study if any of the following criteria apply to you:
- Do not have or are not planning on receiving a DRG stimulator.
This is a partial list of inclusion and exclusion criteria.
Clinical Trial Area:
Pain Management
Contact Phone:
(312) 942-2985
Contact Name:
Sherry Robison